An Efficacy and Safety Study of Plecanatide in Adolescents 12 to <18 Years of Age With Chronic Idiopathic Constipation

Status:
Completed

Trial end date:
2018-09-07

Target enrollment:

Participant gender:

This is a study of efficacy and safety of Plecanatide in pediatric subjects aged 12 to < 18 years diagnosed with Chronic Idiopathic Constipation.

Phase 2

Bausch Health Americas, Inc.
Synergy Pharmaceuticals Inc.

Plecanatide